Literature DB >> 16552546

Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency.

Francois-G Debray1, Marie Lambert, Michel Vanasse, Jean-Claude Decarie, Jessie Cameron, Valeriy Levandovskiy, Brian H Robinson, Grant A Mitchell.   

Abstract

Two unrelated children presenting with episodic isolated peripheral weakness were found to have pyruvate dehydrogenase (PDH) deficiency (OMIM 312170) due to previously undescribed mutations (Pro250Thr, Arg88Cys) in the gene for the E1alpha subunit (PDHA1). Taken in context with the literature, these patients suggest that acute weakness initially resembling Guillain-Barré syndrome is a potentially reversible and probably underdiagnosed manifestation of PDH deficiency and that peripheral nerve function should be evaluated in PDH-deficient patients.

Entities:  

Mesh:

Year:  2006        PMID: 16552546     DOI: 10.1007/s00431-006-0104-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

Review 1.  Variants and mimics of Guillain Barré Syndrome.

Authors:  Kerry H Levin
Journal:  Neurologist       Date:  2004-03       Impact factor: 1.398

2.  Caveats when considering ketogenic diets for the treatment of pyruvate dehydrogenase complex deficiency.

Authors:  T A Weber; M R Antognetti; P W Stacpoole
Journal:  J Pediatr       Date:  2001-03       Impact factor: 4.406

3.  Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex.

Authors:  B H Robinson; H MacMillan; R Petrova-Benedict; W G Sherwood
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

4.  Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations.

Authors:  I D Wexler; S G Hemalatha; J McConnell; N R Buist; H H Dahl; S A Berry; S D Cederbaum; M S Patel; D S Kerr
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

Review 5.  Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency.

Authors:  W Lissens; L De Meirleir; S Seneca; I Liebaers; G K Brown; R M Brown; M Ito; E Naito; Y Kuroda; D S Kerr; I D Wexler; M S Patel; B H Robinson; A Seyda
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

6.  Congenital lactic acidosis due to a defect of pyruvate dehydrogenase complex (E1). Clinical, biochemical, nerve biopsy study and effect of therapy.

Authors:  A Federico; M T Dotti; G M Fabrizi; S Palmeri; L Massimo; B H Robinson; A Malandrini; G C Guazzi
Journal:  Eur Neurol       Date:  1990       Impact factor: 1.710

7.  Deficiency of pyruvate dehydrogenase caused by novel and known mutations in the E1alpha subunit.

Authors:  Jessie M Cameron; Valeriy Levandovskiy; Neviana Mackay; Ingrid Tein; Brian H Robinson
Journal:  Am J Med Genet A       Date:  2004-11-15       Impact factor: 2.802

8.  E1 pyruvate dehydrogenase deficiency in a child with motor neuropathy.

Authors:  G Bonne; C Benelli; L De Meirleir; W Lissens; M Chaussain; M Diry; J P Clot; G Ponsot; V Geoffroy; J P Leroux
Journal:  Pediatr Res       Date:  1993-03       Impact factor: 3.756

9.  Pyruvate dehydrogenase deficiency presenting as dystonia in childhood.

Authors:  R A Head; C G E L de Goede; R W N Newton; J H Walter; M A McShane; R M Brown; G K Brown
Journal:  Dev Med Child Neurol       Date:  2004-10       Impact factor: 5.449

10.  Leigh syndrome: pyruvate dehydrogenase defect. A case with peripheral neuropathy.

Authors:  B Chabrol; J Mancini; C Benelli; C Gire; A Munnich
Journal:  J Child Neurol       Date:  1994-01       Impact factor: 1.987

View more
  8 in total

Review 1.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

2.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

3.  Pyruvate dehydrogenase-e1α deficiency presenting as recurrent demyelination: an unusual presentation and a novel mutation.

Authors:  Pratibha Singhi; Linda De Meirleir; Willy Lissens; Sunit Singhi; Arushi Gahlot Saini
Journal:  JIMD Rep       Date:  2013-02-12

4.  Simulations of Pathogenic E1α Variants: Allostery and Impact on Pyruvate Dehydrogenase Complex-E1 Structure and Function.

Authors:  Hatice Gokcan; Jirair K Bedoyan; Olexandr Isayev
Journal:  J Chem Inf Model       Date:  2022-07-07       Impact factor: 6.162

Review 5.  Peripheral neuropathy and inborn errors of metabolism in adults.

Authors:  F Sedel; C Barnerias; O Dubourg; I Desguerres; O Lyon-Caen; Jean-Marie Saudubray
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

6.  Sensory-motor polyneuropathy occurring in variant maple syrup urine disease.

Authors:  S Harty; M D King; B McCoy; D Costigan; E P Treacy
Journal:  J Inherit Metab Dis       Date:  2008-10-16       Impact factor: 4.982

Review 7.  Inborn errors of metabolism and motor disturbances in children.

Authors:  A García-Cazorla; N I Wolf; M Serrano; B Pérez-Dueñas; M Pineda; J Campistol; E Fernández-Alvarez; J Colomer; S DiMauro; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2009-10       Impact factor: 4.982

8.  Integrative metabolomics reveals unique metabolic traits in Guillain-Barré Syndrome and its variants.

Authors:  Soo Jin Park; Jong Kuk Kim; Hyun-Hwi Kim; Byeol-A Yoon; Dong Yoon Ji; Chang-Wan Lee; Ho Jin Kim; Kyoung Heon Kim; Ha Young Shin; Sung Jean Park; Do Yup Lee
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.